Sanofi
A global biopharmaceutical company that discovers, develops, and markets medicines and vaccines.
SAN | PA
Overview
Corporate Details
- ISIN(s):
- FR0000120578 (+39 more)
- LEI:
- 549300E9PC51EN656011
- Country:
- France
- Address:
- 46 AVENUE DE LA GRANDE ARMEE, 75017 PARIS
- Sector:
- Manufacturing
Description
Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-07-31 07:30 |
Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales…
|
English | 316.3 KB | ||
| 2025-07-31 00:00 |
Sanofi - Rapport semestriel 2025
|
French | 1.6 MB | ||
| 2025-07-30 14:09 | English | 6.4 KB | |||
| 2025-07-30 07:00 |
Communiqué de presse: Le SAR446523 de Sanofi, un anticorps monoclonal anti-GPRC…
|
French | 215.7 KB | ||
| 2025-07-30 07:00 |
Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan d…
|
English | 206.4 KB | ||
| 2025-07-29 18:18 | English | 7.8 KB | |||
| 2025-07-28 18:30 |
Sanofi : Déclaration des transactions sur actions propres
|
French | 2.8 MB | ||
| 2025-07-28 18:30 |
Sanofi: Disclosure of trading in own shares
|
English | 2.8 MB | ||
| 2025-07-25 07:00 |
Communiqué de presse : Sarclisa de Sanofi approuvé dans l’UE pour le traitement…
|
French | 228.1 KB | ||
| 2025-07-25 07:00 |
Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transp…
|
English | 220.6 KB | ||
| 2025-07-22 14:49 |
6-K
|
English | 39.0 KB | ||
| 2025-07-22 07:30 |
Communiqué de presse : Sanofi va acquérir Vicebio et enrichir son pipeline de v…
|
French | 193.0 KB | ||
| 2025-07-22 07:30 |
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeli…
|
English | 193.8 KB | ||
| 2025-07-21 18:30 |
Sanofi: Disclosure of trading in own shares
|
English | 2.7 MB | ||
| 2025-07-21 18:30 |
Sanofi : Déclaration des transactions sur actions propres
|
English | 2.7 MB |
Automate Your Workflow. Get a real-time feed of all Sanofi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sanofi
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sanofi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-02 | N/A | Other | Buy | 71,423 | N/A |
| 2024-04-26 | N/A | Other | Buy | 1,000 | 91,380.00 EUR |
| 2023-06-09 | N/A | Other | Buy | 9 | 856.04 EUR |
| 2023-05-02 | N/A | Other | Buy | 65,205 | 6,364,008.00 EUR |
| 2023-05-02 | N/A | Other | Buy | 500 | 48,835.00 EUR |
Peer Companies
